The Winniedel Story

Cancer is both highly personal and scientifically complex. Let’s end it, together.

Winniedel was created as a loving testament to the founder, Dr. Tandy Tipps’ father and mother-in-law who both died of cancer within six months of each other.  Through Dr. Tandy Tipps' role as the former Department Administrator of the world's largest Phase 1 program at The University of Texas MD Anderson Cancer Center and working with cancer centers, PIs and KOLs across the world she saw that even the most cutting-edge cancer research could fade into obscurity because of barriers to early phase trial launch in oncology and precision medicine research.

Our Mission

To help bring new, novel, and life-saving therapeutics to cancer patients sooner by applying our optimized SSU model and the GOSU to accelerate results, as well as proven and agile development processes to trials, saving biotech developers time and money.

How Do We Make Cancer History?

By leveraging an extensive global network of deep-rooted professional contacts, Winniedel is capable of marrying the personal and the scientific to expedite the process of matching your trial to the right trial site and the right patients. 

Patients As The Priority

At the heart of oncology clinical research are the patients who need novel innovations in cancer treatment. Clinical trials can provide them with life-saving therapeutics, even as a drug continues development. Every time there are delays in SSU and FPI, it negatively affects the lives of cancer patients who are waiting on a potential cancer treatment. Winniedel is deeply committed to matching the right sites and the right patients to the right oncology trials, while decreasing both SSU and FPI timelines, as well as the failure rate we currently see in cancer drug development.

Over 44% of clinical trials are delayed during study start-up. Let’s change that.

About Our Founder

Dr. Tandy Tipps, MED, MPA, PhD, is the former Department Administrator in Investigational Cancer Therapeutics (the largest Phase 1 program in the world) at The University of Texas MD Anderson Cancer Center. She has held executive roles in global CRO and biopharma ecosystems and has extensive experience in phase FIH/III oncology trials, as well as strong relationships with leading academic, IDN, and community-based research centers across the globe. 

But she is more than that. Dr. Tipps is a 5th generation Texan and also considers herself to be a New Yorker due to the long time she spent living in Manhattan and her love of NYC. She often says that "no one would know that I was not from NYC when I am there until I speak and then they can tell that I do not have a NYC accent!" She is an avid cyclist; a lover of rock concerts; involved in animal rescue; has traveled all over the world (loves to travel); enjoys working in the yard and being outside; enjoys reading non-fiction books and listening to heavy metal; dislikes cold weather and loves the water especially when it involves a jet ski; values kindness, relationships and being truthful and upfront.

What It’s Like to Work with Winniedel

  • Dr. Tandy Tipps is an exceptional collaborator whose insight and dedication consistently elevates the life sciences industry's work. Her approach to advancing healthcare is both visionary and deeply rooted in patient needs, making every project together impactful and inspiring. It’s a privilege to partner with someone who shares GLSA's commitment to excellence and innovation.

    Denise McNerney, Partner at Global Life Sciences Alliance (GLSA)

  • No one knows the sites in the early phase oncology space better than Dr. Tandy Tipps including their areas of therapeutic expertise and where they are actively seeking trials to fit their patients’ needs. In a time where we are seeing overall start-up timelines increase, she can move mountains and help navigate the nuances of site start-up so we can get sites open quicker for enrollment.

    Megan Liles, VP, Clinical Delivery, HGI Clinical

  • Tandy has a rare ability to combine her oncology expertise with her network and a personal touch, consistently delivering fast and effective results. Her dedication and energy were evident throughout, and the success of the completion of the site feasibility was largely due to her contributions.

     Clinical Project Manager for a UK biotech

  • I've worked with Tandy on early-phase trials for over six years. She is integrity-driven, honest, and deeply committed to building strong relationships. As a proven expert in expedited SSU, her close ties with PIs and cancer centers worldwide enable precise trial-to-site matching. Tandy founded WINNIEDEL to put the focus back on cancer patients who need potentially life-saving treatment options faster.

    Glen Weiss, MD, Biotech Executive & Medical Oncologist*

    *Unpaid consultant to WINNIEDEL

  • Tandy is incredibly well respected and connected in the early phase oncology community. Her ability to connect with the right people at the study sites and gauge interest for new early-stage oncology studies, coupled with her professionalism, enthusiasm and tireless pursuit of excellence are all attributes that make her services invaluable

    - EU Biotech Founder

  • Working with Tandy has been truly energizing. Her ability to build meaningful connections and turn ideas into action sets her apart. As she built the Oncology Site Network for Precision for Medicine, I witnessed firsthand how she consistently delivered results while bringing an infectious enthusiasm to every project. What is particularly impressive is Tandy's talent for not just creating robust professional networks, but activating those relationships to achieve meaningful objectives.

    Rob Ott, M.B.A, PMP, Leadership Coach, Ott Management Solutions

  • Tandy collaborated with us to support site feasibility at several trial locations where we were encountering significant challenges. Her longstanding relationships with cancer research centers, developed through years of experience, were instrumental in helping us efficiently overcome these obstacles.

    Clinical Project Manager, U.K. Biotech

  • Having worked with Tandy in a previous organization, I didn’t hesitate to reach out for her advice and support as we faced the complexities of launching a new oncology study in the US and EU. Tandy's deep expertise in oncology site networks was not just helpful but absolutely instrumental in our success. She guided us through every detail, from identifying ideal clinical sites to streamlining the process for site selection, study start-up, and contract negotiation. Tandy’s strategic insights ensured we partnered with the best-equipped sites, helping us achieve our first-patient-in (FPI) milestone on schedule. Her support went far beyond logistics; Tandy’s personal and professional relationships with sites set her apart. She has an unmatched understanding of the clinical trial landscape globally, knowing the specific strengths and capacities of sites not just in the US and EU but worldwide. Her relationships are mirrored by the sites’ responsiveness, making every interaction seamless. I highly recommend Tandy for any oncology clinical study start-up or ongoing site management. Her commitment and the value she brings are invaluable at every step.

    VP Clinical Operations, U.K. Biotech

  • Tandy provided real, tailored solutions for us as,a small biotech company, proving herself an invaluable partner and a true inspiration. Any organization would be fortunate to benefit from her expertise.

    Clinical Project Manager for a UK biotech